Abstract OBJECTIVE: To examine serum tissue inhibitors of metalloproteinases (TIMP) -1 and -2 levels in children with nonalcoholic fatty liver disease and to investigate possible roles of the two markers. METHODS: One hundred and five obese children were classified into 4 groups: simple obesity (n=44), simple nonalcoholic fatty liver (SNAFL, n=25), and nonalcoholic steatohepatitis (NASH, n=36). Serum TIMP-1 and -2 levels were measured using ELISA. Serum ALT and γ-GT levels were measured with totally automatic enzymatic method. RESULTS: Serum levels of TIMP-1 and γ-GT increased with the disease development from simple obesity to SNAFL and NASH (P<0.05). Both serum TIMP-1 and -2 levels were positively correlated with γ-GT levels (r=0.534，P<0.01; r=0.351, P<0.05, respectively). Ninety-seven percent of children in the NASH group had serum TIMP-1 levels over 2 standard deviations of healthy controls (83.35 μg/ L) compared with 76% in the SNAFL group (P﹤0.05). There were no significant differences in the case proportion with TIMP-2 levels over 2 standard deviations of healthy controls between the NASH and the SNAFL groups. CONCLUSIONS: Both TIMP-1 and -2 may reflect the state of liver fibrosis in children with nonalcoholic fatty liver disease, and serum TIMP-1 appears to be more reliable.［Chin J Contemp Pediatr, 2010, 12 (6):455-458］
LI Yu-Wen,ZHU Chuan-Long,GAO Ren-Tao et al. Determination and clinical significance of tissue inhibitors of metalloproteinase-1 and -2 in serum of children with nonalcoholic fatty liver disease[J]. 中国当代儿科杂志, 2010, 12(06): 455-458.
LI Yu-Wen,ZHU Chuan-Long,GAO Ren-Tao et al. Determination and clinical significance of tissue inhibitors of metalloproteinase-1 and -2 in serum of children with nonalcoholic fatty liver disease[J]. CJCP, 2010, 12(06): 455-458.
［2］Nie QH, Cheng YQ, Xie YM, Zhou YX, Bai XG, Cao YZ. Methodologic research on TIMP-1, TIMP-2 detection as a new diagnostic index for hepatic fibrosis and its significance［J］. World J Gastroenterol, 2002, 8(2):282-287.
［6］Pacifico L, Celestre M, Anania C, Paolantonio P, Chiesa C, Laghi A. MRI and ultrasound for hepatic fat quantification: relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease［J］. Acta Paediatr, 2007, 96(4):542-547.
［11］Nie QH, Zhang YF, Xie YM, Luo XD, Shao B, Li J, et al. Correlation between TIMP-1 expression and liver fibrosis in two rat liver fibrosis models ［J］. World J Gastroenterol, 2006, 12(19):3044-3049.
［12］Murawaki Y, Ikuta Y, Kawasaki H. Clinical usefulness of serum tissue inhibitor of metalloproteinase (TIMP)-2 assay in patients with chronic liver disease in comparison with serum TIMP-1［J］. Clin Chim Acta, 1999, 281(1-2):109-120.
